Two conditions known to be associated with anti-TNF antibody treatment of rheumatoid arthritis, namely increased infection with M. tuberculosis and occurrence of Merkel cell carcinomas, have both been identified as being kept at bay by TNF-secreting lymphocytes [20,21], respectively. This evidence concerns the gene TNF and Merkel cell skin cancer.